CF Foundation letter thanking the California Department of Health Care Services for including certain CF medications on the state's list of medications eligible for extended duration prior authorization under Medi-Cal Rx and requesting the inclusion of additional medications to that list.
Site Search
Ad hoc coalition comment letter to HHS opposing a proposal to implement Medicaid work requirements in Arkansas.
The Foundation sends a letter to leaders of the House Energy & Commerce Committee urging passage of H.R. 3008, 3793 and 3810 which would help mitigate drug shortages and ensure patients will have access to all necessary medications.
CF Foundation letter to New York’s governor asking that she sign a bill that would reinstate the Adult CF Assistance Program.
The Cystic Fibrosis Foundation along with directors of Colorado's Cystic Fibrosis care centers sent a letter to the state's Prescription Drug Affordability Board commenting on the list of prioritized drugs eligible for an affordability review.
In its response, sent to the U.S. House of Representatives Budget Committee Health Care Task Force, the Foundation commented on how legislation to combat the antimicrobial resistance crisis, such as the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (H.R.
The Foundation calls on the health plan to reverse its decision to remove CFTR modulators from marketplace and small employer plan formularies as required by patient protections guaranteed in the Affordable Care Act. The letter was also sent to insurance commissioners in Utah, Nevada, Colorado, and Idaho.
Ad hoc patient advocacy coalition provided feedback to the U.S. Department of Health and Human Services on Massachusetts’ proposal to provide retroactive Medicaid coverage, continuous eligibility, and increased eligibility for marketplace subsidies.
The Cystic Fibrosis Foundation expressed support to the New Jersey General Assembly for A1255, Ensuring Transparency in Prior Authorization, which makes several important reforms to the prior authorization process.
The Cystic Fibrosis Foundation sent feedback to the Maryland Prescription Drug Affordability Board on their proposed Cost Review Study Process.